Schedule 13D ownership disclosure
ALZAMEND NEURO INC
Common Stock, par value $0.0001 per share · CUSIP: 02262M605
Event date: 2025-09-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- MILTON C. AULT, IIIReported CIK 0001212502
Shares: 509,315.00 · Class: 13.3%
- WILLIAM B. HORNEReported CIK 0001333268
Shares: 3,518.00 · Class: 0.1%
- HENRY C.W. NISSERReported CIK 0001775938
Shares: 926.00 · Class: 0.0%
- KENNETH S. CRAGUNReported CIK 0001327261
Shares: 1,111.00 · Class: 0.0%
- DAVID J. KATZOFFReported CIK 0001864317
Shares: 1,726.00 · Class: 0.1%
- HYPERSCALE DATA, INC.Reported CIK 0000896493
Shares: 496,343.00 · Class: 13.0%
- AULT LENDING, LLC
Shares: 496,331.00 · Class: 13.0%
- AULT LIFE SCIENCES, INC.
Shares: 11,068.00 · Class: 0.3%
- AULT LIFE SCIENCES FUND, LLC
Shares: 61.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-014211
- Form type
- SCHEDULE 13D/A
- Filer
- AULT MILTON C III
- CIK
- CIK 1212502
- Filed
- Sep 25, 2025
- Reporting period
- Sep 23, 2025
- Description
- Schedule 13D beneficial ownership